Peptide signaling
CJC-1295 w/ DAC
Drug-affinity-complex GHRH analog
DAC-linked GHRH analog · GH-axis research
A DAC-linked GHRH analog studied for half-life extension, albumin binding, and GH-axis pathway signaling in controlled research models.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Vial size
Research-use catalog price
$59
SKU ABL-CD2-2
Lot ABL-CD2-2606 · COA traceable · Research-use-only attestation required
Specifications
CJC-1295 w/ DAC is a modified GHRH analog designed with a drug-affinity-complex group that supports reversible albumin binding.
It is distinct from no-DAC CJC-1295 and is typically discussed in long-acting GHRH analog literature.
Studies on DAC-linked GHRH analogs have examined pharmacokinetic extension, receptor-mediated GH-axis signaling, and downstream IGF-1 pathway response.
Related research tools
